The Bangladesh Economic Zones Authority (BEZA) has officially handed over 30 acres of land to Delta Life Sciences PLC at the National Special Economic Zone (NSEZ) in Chattogram.
This land transfer is part of a larger plan by Delta Life Sciences to invest approximately $30 million in a state-of-the-art pharmaceutical manufacturing facility, BEZA said in a statement on Friday.
The project is expected to generate around 700 direct jobs and includes the establishment of multiple advanced facilities, such as a biopharmaceutical fill-finish and formulation unit, oncology manufacturing facility, and an R&D centre.
Delta Life Sciences, a subsidiary of Delta Pharma Limited, aims to meet both local and international market demands with high-quality pharmaceutical products.
Delta Pharma, established in 1964, has been a significant contributor to Bangladesh’s healthcare sector and is known for its adherence to WHO Good Manufacturing Practices (GMP) and ISO 9001:2015 standards.
BEZA’s Executive Chairman Chowdhury Ashik Mahmud bin Harun congratulated Delta Life Sciences, noting that this investment will diversify pharmaceutical production, create employment, and strengthen the country’s healthcare capacity.
Dr Md Zakir Hossain, Managing Director of Delta Life Sciences PLC, expressed optimism about the project and stated that the company is aiming to begin production of oral solid medicines and oncology treatments within the next three years.
The land handover was formally completed by BEZA’s Director General for Investment Development, Mohammad Ahsan Ullah.
The National Special Economic Zone currently hosts 17 operational industrial units, with 28 more under construction.
This planned industrial zone, stretching 25 kilometres along the coastline, is set to become the largest of its kind in Bangladesh, combining industrial facilities with essential urban infrastructure.
